Strengthen antibodies, block skin irritation and sensitivity, and seize the golden period of immunity before age 5.
The gut is the largest immune organ in the human body (70% of immune cells are concentrated in the gut), while the skin is the largest organ. The balance of the gut microbiota not only affects the function of the immune system but also plays a crucial role in the skin's protective barrier.
A recent study in the United States indicates that children are particularly prone to allergic skin conditions because their immune systems are not yet fully developed. The antibodies they inherit from their mothers begin to weaken from around 6 months of age (which is also the earliest time allergies develop), and they haven't yet developed their own antibodies. During this period, their immunity is weaker, and they are more susceptible to infection.
For children, the immune system doesn't fully develop until around 6-7 years of age, and the first 5 years are a critical period for immune system development and a golden period for strengthening the immune system.
Experts at the American Academy of Dermatology believe that the immune system of patients with allergic skin conditions may confuse healthy skin cells with minor environmental irritants as foreign invaders, causing an overreaction that attacks skin cells and leads to allergy symptoms.
G-NiiB Immune Kids SIM03
It is a unique microbiome formula that can be used as a dietary supplement. This formula uses big data to select ideal naturally occurring live bacteria, with patented microencapsulated technology from Italy to enhance live bacteria survival and is clinically shown to be effective and safe in local children with sensitive skin. This formula is scientifically formulated with exclusive patent licensing and clinically studied by The Faculty of Medicine of a Renowned University in Hong Kong.
Studies have shown that the formula not only significantly reduced the infected area and intensity by 38.9% but also reduced the sensitivity index from moderate to mild in 100% of children with moderate eczema sensitivity and improved from severe to moderate in 50% of children with severe eczema sensitivity. The data confirms that the treatment effect increases over time, with the moderately sensitive skin group achieving comprehensive improvement and half of the severely sensitive skin group experiencing effective relief.
Purchase link:
https://g-niib.com/products/g-niib-immune-kids-sim03
References:
Eichenfield LF, et al (2014). Guidelines of care for the management of A.D.: section 1. Diagnosis and assessment of A.D. Journal of the American Academy of Dermatology, 70(2), 338–351. https://doi.org/10.1016/j.jaad.2013.10.010
Kloc, M., Ghobrial, R. M., Kuchar, E., Lewicki, S., & Kubiak, J. Z. (2020). Development of child immunity in the context of ... Clinical immunology (Orlando, Fla.), 217, 108510. https://doi.org/10.1016/j.clim.2020.108510
Simon, A. K., Hollander, G. A., & McMichael, A. (2015). Evolution of the immune system in humans from infancy to old age. Proceedings. Biological sciences, 282(1821), 20143085. https://doi.org/10.1098/rspb.2014.3085
